
Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

The venture capital arm of Astellas, investing in early-stage biomedicine and therapeutics companies

Astellas Venture Management is the venture capital organisation wholly owned by Astellas, supporting pre-clinical science that its investment team believes can bring value to patients. For more than 20 years it has made equity investments in private, early-stage companies developing therapeutic programmes and platform technologies, aiming to help them advance more quickly. It describes itself as a strategic investor, making investments in science that could strengthen Astellas's own research and development pipeline or open up new directions in discovery research. Its site lists news of portfolio companies, including funding rounds and clinical trial milestones, and an annual prize it runs jointly with MBC BioLabs to recognise early-stage innovators in the life sciences.
Profile written by TrustList from the business's own published information, Sep 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Astellas Venture Management.
Similar listings buyers compare against this one.

Corporate venture arm of Johnson & Johnson investing in healthcare companies from seed stage onwards

Hybrid investment and advisory firm backing fintech startups facing financial and regulatory change

Chicago-linked impact venture firm opening venture investing to diverse founders, investors and emerging fund managers

Investment manager focused on mortgage credit, mortgage servicing rights and real estate technology ventures

Seed-stage venture investor backing enterprise cloud software startups that modernise traditional industries

An early-stage venture firm investing in business software companies working on the future of work and education
Everything here links back to the same verified catalogue. Pick your next stop.